OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 02, 2010
When it comes to healthcare rform, we must not overlook investment in innovative technologies.
Leading experts share insight on the current and future direction of process analytical technology. This article contains bonus online material.
We never thought implementing complex changes could become more cumbersome.
January 28, 2010
Novartis CEO To Step Down; DSM To Close Netherlands Facility; And More.
January 21, 2010
Lonza Group (Basel) plans to reinforce its presence in Asia, including its platform in Nansha, China, and to close its Conshohocken (Riverside), Pennsylvania; Shawinigan, Canada; and Wokingham, United Kingdom, sites in 2010.
FDA Issues Warning Letter To McNeil Healthcare; Charles River Laboratories Will Suspend Operations At Massachusetts Facility.
January 07, 2010
Bioject Medical Technologies establishes alliance with MPI Research; Biogen Idec CEO to retire; And More.
January 02, 2010
Grace McNally, in the Office of Compliance at FDA's CDER, discusses the role of QbD and pharmaceutical quality systems as it relates to contract manufacturing.
Team leaders in FDA's Office of Generic Drugs provide an overview.
Plus, novel dosage forms and emerging trends.